What is the category of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl ?
The category of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl is Equity - Sector - Healthcare
What is the current NAV of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl ?
The current NAV of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl
(as on Mar 13, 2025) is
₹ 152.14
How safe is Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl?
The risk level of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl is Very High .
What are short term returns given by Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl?
The return given by Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl in
1 month is -2.95%,
3 months is -9.29%,
6 months is -12.36%,
and 1 year is 11.68%.
What are the long term returns given by Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl?
The return given by Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl in
3 years is 18.00% and
5 years is 29.01%.
What is the expense ratio of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl?
The expense ratio of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl is
1.03 %
What is the AUM of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl
The assets under Management (AUM) of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl is
Rs 8,160.74 crores.
What is the minimum investment in Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl?
The minimum Lumpsum investment in Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl is
₹5000
and the minimum SIP investment in Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl is ₹100
What is the asset allocation of Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl?
The Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl has an exposure of
98.89%
in Equity,
and
1.11%
in Cash
& Money Market Securities